Presentation and detection of invasive melanoma in a high-risk population

Journal of the American Academy of Dermatology
Michelle McPhersonJoanne F Aitken

Abstract

Early detection of melanoma has been encouraged in Queensland for many years, yet little is known about the patterns of detection and the way in which they relate to tumor thickness. Our purpose was to describe current patterns of melanoma detection in Queensland. This was a population-based study, comprising 3772 Queensland residents diagnosed with a histologically confirmed melanoma between 2000 and 2003. Almost half (44.0%) of the melanomas were detected by the patients themselves, with physicians detecting one fourth (25.3%) and partners one fifth (18.6%). Melanomas detected by doctors were more likely to be thin (<0.75 mm) than those detected by the patient or other layperson. Melanomas detected during a deliberate skin examination were thinner than those detected incidentally. Although a participation rate of 78% was achieved, as in any survey, nonresponse bias cannot be completely excluded, and the ability of the results to be generalized to other geographical areas is unknown. There are clear differences in the depth distribution of melanoma in terms of method of detection and who detects the lesions that are consistent with, but do not automatically lead to, the conclusion that promoting active methods of detection may...Continue Reading

References

Jun 1, 1992·Journal of the American Academy of Dermatology·H K KohR A Lew
Nov 3, 1990·BMJ : British Medical Journal·R M MacKie
Mar 1, 1988·Journal of the American Academy of Dermatology·B R CassilethM S Blois
Nov 1, 1980·Preventive Medicine·D Mechanic, P D Cleary
May 1, 1995·World Journal of Surgery·R C Burton, B K Armstrong
Sep 1, 1994·Clinical and Experimental Dermatology·J MeliaJ Chamberlain
Mar 1, 1994·Preventive Medicine·A HeywoodP Mudge
Apr 1, 1994·Melanoma Research·R C Burton, B K Armstrong
Jun 1, 1996·Journal of the American Academy of Dermatology·D R MillerH K Koh
Feb 24, 1999·JAMA : the Journal of the American Medical Association·D S EpsteinS E Koch
Dec 22, 1999·Archives of Dermatology·D M LipskerB J Cribier
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·M A RichardP Chemaly
Aug 5, 2000·Cancer·M S BradyA C Halpern
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E NagoreJ M Fortea
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·L D MarrettB K Armstrong
Apr 18, 2001·American Journal of Preventive Medicine·UNKNOWN US Preventive Services Task Force
Apr 21, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L BrochezJ M Naeyaert
May 3, 2001·Journal of the National Cancer Institute·A JemalM A Tucker
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BrayD M Parkin
Apr 12, 2002·Journal of Medical Screening·J F AitkenI T Ring
Aug 10, 2002·Melanoma Research·M H Schmid-WendtnerM Volkenandt
Oct 9, 2002·Journal of Medical Screening·P F HanrahanP Hersey
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
May 25, 2004·American Journal of Epidemiology·J F AitkenD W Firman
Aug 3, 2004·Cancer Causes & Control : CCC·Joanne F AitkenDavid W Firman
Nov 20, 2004·Clinical and Experimental Dermatology·P CarliB Giannotti
Jan 13, 2006·The Australasian Journal of Dermatology·Gordon J Rennick
Jan 18, 2006·Cancer Causes & Control : CCC·Michael CooryIan Ring

❮ Previous
Next ❯

Citations

Apr 22, 2009·Archives of Dermatology·June K RobinsonJerod Stapleton
Jan 20, 2010·Archives of Dermatology·June K RobinsonMaliya Pion
Apr 8, 2011·Cancer Causes & Control : CCC·Anne E CustGraham J Mann
Jun 13, 2009·Journal of Behavioral Medicine·Nadine A KasparianBettina Meiser
Nov 29, 2007·Internal and Emergency Medicine·D BonucchiP A Modesti
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Susan A OliveriaAllan C Halpern
May 23, 2012·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Waqas R ShaikhMartin A Weinstock
Feb 3, 2007·Current Opinion in Oncology·Allan C Halpern, Jocelyn A Lieb
Oct 4, 2012·Future Oncology·Alejandro Conde-Perez, Lionel Larue
Aug 26, 2014·Advances in Therapy·Alfonso BerrocalJosé Luis Rodríguez-Peralto
Aug 1, 2012·Journal of Skin Cancer·Cindy L LamersonMohammed Kashani-Sabet
Nov 28, 2015·Journal of the American Academy of Dermatology·Jamie L HansonErin M Warshaw
Feb 25, 2014·Clinics in Dermatology·Heidi M HermesJason B Lee
Aug 21, 2013·Seminars in Oncology Nursing·Lois J LoescherClara Curiel-Lewandrowski
Mar 12, 2013·Journal of the American Academy of Dermatology·Jennifer E McWhirter, Laurie Hoffman-Goetz
Apr 25, 2009·Journal of the American Academy of Dermatology·Agnessa Gadeliya Goodson, Douglas Grossman
Aug 13, 2008·Journal of the American Academy of Dermatology·Dirk Michael ElstonErin O Kaleba
May 20, 2008·Journal of the American Academy of Dermatology·Seth B FormanDirk M Elston
Jul 27, 2015·Actas dermo-sifiliográficas·M Ivars, P Redondo
Sep 18, 2007·Journal of the American Academy of Dermatology·Alan C GellerAmy L Yaroch
Dec 28, 2006·Journal of the American Academy of Dermatology·Warren R Heymann
Dec 30, 2014·Health and Quality of Life Outcomes·Ngadiman DjajaMonika Janda
Nov 18, 2009·The Australasian Journal of Dermatology·Paul Cherian, Clare P Tait
Aug 8, 2009·The Australasian Journal of Dermatology·Susan L BooneKimberly A Mallett
Nov 7, 2008·International Journal of Dermatology·Reyhaneh HamidiDavid H Peng
Jan 16, 2007·The Australasian Journal of Dermatology·Scott BarkerMarius Rademaker
Jul 8, 2010·International Journal of Cancer. Journal International Du Cancer·Philippa H YoulJoanne F Aitken
Mar 23, 2011·Clinical and Experimental Dermatology·L TrolleR Gniadecki
Aug 31, 2012·Psycho-oncology·Jordana McLooneNadine A Kasparian
May 25, 2011·The Australasian Journal of Dermatology·Victoria MarJohn W Kelly
Jul 18, 2009·International Journal of Cancer. Journal International Du Cancer·Joanne F AitkenDallas English
May 15, 2010·International Journal of Dermatology·Reyhaneh HamidiMyles Cockburn
May 26, 2009·Hematology/oncology Clinics of North America·Vitaly Terushkin, Allan C Halpern
Dec 18, 2007·Seminars in Oncology·Jeremy S BordeauxKevin D Cooper
Jun 4, 2015·The British Journal of Dermatology·A Finnane, H P Soyer
Sep 21, 2016·Journal of the American Academy of Dermatology·José Antonio Avilés-IzquierdoPablo Lazaro-Ochaita
Nov 22, 2016·International Journal of Environmental Research and Public Health·Philippa H YoulPeter D Baade
Jan 18, 2013·Journal of Health Psychology·Senada HajdarevicAsa Hörnsten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.